Greenway Medical Technologies, Inc., provider of the single-database electronic health record (EHR), practice management and interoperability solution PrimeSUITE®, is exhibiting its PrimeRESEARCH™ solutions at the DIA 2012 48th Annual Meeting June 24-28 in Philadelphia. PrimeRESEARCH’s EHR-enabled technology connects life science companies and contract research organizations (CROs) with physician practices that use PrimeSUITE to document patient health records. To date, Greenway® has coordinated participation of PrimeRESEARCH sites in more than 40 clinical studies, including Phase II-IV, Observational, Registry and Safety studies, across a range of therapeutic areas. Using de-identified queries run across the PrimeRESEARCH network, Greenway helps study sponsors and CROs test the feasibility of study protocols and identify sites with sufficient patient population. Study-eligible patients are then identified to participating sites based on protocol inclusion and exclusion criteria to facilitate recruitment. This reduces the need for time-consuming chart searches by site staff. Eligibility can be flagged within PrimeSUITE at the point of care, and data for enrolled patients can be extracted from PrimeSUITE and loaded into a study database or mapped into an electronic data capture (EDC) case report form, decreasing duplicate data entry and making study participation easier for sites. “We have seen high levels of sponsor and CRO satisfaction with our innovative options for investigator site selection, patient recruitment, data collection and monitoring,” said Greenway Vice President of PrimeRESEARCH Sam Holliday. “Our integrated remote monitoring solution has been particularly effective in reducing the amount of on-site source document verification and providing early detection of protocol deviations and serious adverse events (SAEs).” The PrimeRESEARCH Remote Monitoring Solution (RMS) enables sponsors and CROs to perform more flexible and efficient source document verification and reduce on-site visits through view-only access to health records of enrolled subjects via a secure, online portal that includes a full audit trail. “The goal of PrimeRESEARCH is to improve population heath by connecting life science companies developing new treatments to practices whose patients may benefit from these therapies,” said Greenway President and CEO Tee Green. “Greenway continues to grow its network of PrimeRESEARCH sites and add innovative capabilities that contribute to the advancement of medical knowledge, improve the speed and lower the cost of clinical research, and ultimately benefit healthcare providers, patients and the life science industry.”
Visit Greenway and the PrimeRESEARCH team at the DIA 2012 Annual Meeting, Booth 2503.About DIA DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India and Beijing, China. www.diahome.org. About Greenway and PrimeSUITE Greenway Medical Technologies, Inc. (NYSE: GWAY) delivers smarter solutions for smarter healthcare ™. PrimeSUITE ® — Greenway’s certified and fully integrated electronic health record, practice management and interoperability solution — helps improve care coordination, quality and cost-efficiency as part of a smarter, sustainable healthcare system. Thousands of providers across 30 specialties and sub-specialties use on-premise or cloud-based Greenway ® solutions in physician practices, clinics and health systems. To learn more, go to greenwaymedical.com , Twitter, Facebook and YouTube, or email email@example.com . Forward-Looking Statements In addition to historical information, this press release may include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the company’s financial condition, growth strategy, business development efforts, service offerings, and service delivery models. Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the company’s future performance include, but are not limited to, our ability to adapt to evolving technology and industry standards; our ability to implement our growth strategy; our ability to retain management and other qualified personnel; failure to prevent disruptions in service or damage to our third-party providers’ data centers; failure to avoid liability for the use of content we provide; regulation of the healthcare information technology industry; our ability to ensure our solutions meet industry and government standards; failure to maintain adequate security measures for our customers’ confidential information and personal identifiable information and their patients’ protected health information; our ability to obtain new provider clients; failure of the HITECH Act and other incentive programs to be fully implemented or funded by the government; our ability to implement our strategic relationships as currently intended; failure to establish, protect or enforce our intellectual property; restrictions in our credit facility and future indebtedness. The company disclaims any obligation or duty to update or modify these forward-looking statements.
Greenway, the Greenway logo, PrimeSUITE and PrimeRESEARCH are registered trademarks and the phrase “smarter solutions for smarter healthcare” are trademarks of Greenway Medical Technologies, Inc. Other product and company names may be the trademarks of respective owners.